EyePoint Pharmaceuticals Inc.
EYPT | NASDAQ
$4.14
+$0.12 (+2.99%)
Sep 22, 2026, 12:46 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -5.76 | -3.21 | -12.37 | -1.28 | -6.03 | -1.86 |
PEG Ratio | -0.16 | -0.12 | 0.37 | -0.04 | 0.14 | 0.04 |
PS Ratio | 42.66 | 9.69 | 19.04 | 3.15 | 9.53 | 2.45 |
PB Ratio | 4.37 | 1.25 | 3.29 | 1.36 | 1.91 | 4.56 |
P/FCF Ratio | -5.50 | -3.22 | -544.85 | -1.94 | -7 | -5.71 |
P/OCF Ratio | -5.57 | -3.32 | 467.26 | -2.01 | -7.03 | -5.85 |
OCF/S Ratio | -765.39 | -291.70 | 4.07 | -157 | -135.62 | -41.92 |
Debt / Equity Ratio | 0.07 | 0.06 | 0.02 | 0.48 | 0.21 | 2.21 |
Quick Ratio | 8.83 | 7.77 | 5.39 | 4.92 | 9.90 | 3.88 |
Current Ratio | 8.88 | 7.81 | 5.45 | 5 | 10.05 | 4.24 |
Asset Turnover | 0.09 | 0.10 | 0.13 | 0.23 | 0.14 | 0.38 |
Interest Coverage | 7.38K | -10.42K | -60.20 | -31.24 | -10.05 | -5.14 |
Return on Equity | -75.78% | -38.89% | -26.58% | -106.11% | -31.68% | -244.83% |
Return on Assets | -63.73% | -31.27% | -19.93% | -56.70% | -22.18% | -49.49% |
Return on Invested Capital | -73.99% | -39.48% | -25.71% | -63.51% | -22.98% | -48.11% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 93.41% | 91.42% | 89.93% | 79.89% | 77.86% | 83.09% |
Net Profit Margin | -739.42% | -302.43% | -153.84% | -246.97% | -158.14% | -131.82% |
Pretax Profit Margin | -738.53% | -302.22% | -153.66% | -246.97% | -158.14% | -131.82% |
Operating Profit Margin | -775.98% | -337.06% | -163.13% | -240.65% | -149.64% | -108.28% |
FCF Margin | -775.84% | -301.06% | -3.49% | -162.19% | -136.04% | -42.97% |
EBITDA Margin | -731.06% | -298.63% | -149.94% | -233.36% | -135.76% | -103.05% |
Add to Watchlist
Select watchlists to add or remove EYPT